Bactolife

Biotechnology ResearchHovedstaden, Denmark51-200 Employees

Bactolife is a Danish biotechnology research company headquartered in Copenhagen, employing 51-200 people. It develops Binding Proteins, natural ingredients intended for use in foods, beverages, or supplements to selectively block harmful microbial activity while preserving the beneficial microbiome. The company's mission centers on advancing global gut health and contributing to the fight against antimicrobial resistance, with products designed for diverse populations including mothers, children, the elderly, immune-compromised individuals, travelers, and animals. Bactolife has received backing from investors such as Novo Holdings, the Bill & Melinda Gates Foundation, and Innovation Fund Denmark, and completed a Series B financing round with Cross Border Impact Ventures. Beginning in 2026, the company expanded offices to Europe and Asia, launched binding protein products for human health, and entered a strategic partnership with AceBiome to introduce a probiotic-binding protein product in Korea.

Sign up for free to view info

Email Format Employee directory